Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $2.93 billion. The enterprise value is $2.11 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 102.21 million shares outstanding. The number of shares has increased by 24.92% in one year.
| Current Share Class | 102.21M |
| Shares Outstanding | 102.21M |
| Shares Change (YoY) | +24.92% |
| Shares Change (QoQ) | +15.40% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 106.20% |
| Float | 102.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.37 |
| Forward PS | 35.12 |
| PB Ratio | 4.95 |
| P/TBV Ratio | 4.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 29.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.65, with a Debt / Equity ratio of 0.07.
| Current Ratio | 12.65 |
| Quick Ratio | 12.37 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -73.44 |
Financial Efficiency
Return on equity (ROE) is -49.16% and return on invested capital (ROIC) is -30.95%.
| Return on Equity (ROE) | -49.16% |
| Return on Assets (ROA) | -27.67% |
| Return on Invested Capital (ROIC) | -30.95% |
| Return on Capital Employed (ROCE) | -43.85% |
| Weighted Average Cost of Capital (WACC) | 9.76% |
| Revenue Per Employee | $281,147 |
| Profits Per Employee | -$1.12M |
| Employee Count | 252 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.25% in the last 52 weeks. The beta is 1.01, so VRDN's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +72.25% |
| 50-Day Moving Average | 30.52 |
| 200-Day Moving Average | 23.71 |
| Relative Strength Index (RSI) | 45.33 |
| Average Volume (20 Days) | 1,254,484 |
Short Selling Information
The latest short interest is 7.82 million, so 7.65% of the outstanding shares have been sold short.
| Short Interest | 7.82M |
| Short Previous Month | 7.76M |
| Short % of Shares Out | 7.65% |
| Short % of Float | 7.65% |
| Short Ratio (days to cover) | 5.44 |
Income Statement
In the last 12 months, VRDN had revenue of $70.85 million and -$281.93 million in losses. Loss per share was -$3.32.
| Revenue | 70.85M |
| Gross Profit | -268.08M |
| Operating Income | -363.40M |
| Pretax Income | -342.60M |
| Net Income | -281.93M |
| EBITDA | -362.94M |
| EBIT | -363.40M |
| Loss Per Share | -$3.32 |
Full Income StatementBalance Sheet
The company has $874.65 million in cash and $52.59 million in debt, with a net cash position of $822.06 million or $8.04 per share.
| Cash & Cash Equivalents | 874.65M |
| Total Debt | 52.59M |
| Net Cash | 822.06M |
| Net Cash Per Share | $8.04 |
| Equity (Book Value) | 722.17M |
| Book Value Per Share | 5.80 |
| Working Capital | 823.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$276.39 million and capital expenditures -$495,000, giving a free cash flow of -$276.89 million.
| Operating Cash Flow | -276.39M |
| Capital Expenditures | -495,000 |
| Free Cash Flow | -276.89M |
| FCF Per Share | -$2.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -512.91% |
| Pretax Margin | -483.57% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.92% |
| Shareholder Yield | -24.92% |
| Earnings Yield | -9.62% |
| FCF Yield | -9.45% |
Analyst Forecast
The average price target for VRDN is $40.92, which is 42.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.92 |
| Price Target Difference | 42.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 79.90% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 3.27 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.27 |
| Piotroski F-Score | 2 |
